Dr. Oliver Bathe is a leader in Precision Oncology and a Professor of Surgery and Oncology at the University of Calgary. A prolific researcher and passionate advocate for Team Science, Dr. Bathe has played a leading role in international initiatives such as The Cancer Genome Atlas (TCGA), the Clinical Proteomic Tumor Analysis Consortium (CPTAC), and cooperative clinical trial networks.
At the forefront of innovation, Dr. Bathe’s lab harnesses the power of bioinformatics and AI to uncover new molecular subtypes of cancer—paving the way for novel therapeutic targets and predictive tools that personalize treatment for each patient. His team’s groundbreaking machine learning algorithm, designed to pinpoint genes driving aggressive tumor growth, has been deployed across multiple cancer types using supercomputing technology. The result: powerful prognostic signatures that can transform how oncologists tailor treatment plans.
This pioneering work is the foundation of Qualisure Diagnostics Inc., a company Dr. Bathe co-founded to translate cutting-edge science into real-world solutions that are shaping the future of cancer care.
